Prescription Drug News and Research

RSS

ASIPP announces educational campaign to improve chronic pain patients’ quality of life

In recognition of September's designation as National Pain Awareness Month, the American Society of Interventional Pain Physicians (ASIPP) today announced that it is planning a month-long educational campaign to improve the quality of life for the approximately 75 million Americans suffering from acute and chronic pain.

3 Sep 2010

National Drug Control Policy announces $22 million grant in DFC program

Gil Kerlikowske, Director of National Drug Control Policy (ONDCP), today announced $22 million in new Drug Free Communities Support Program (DFC) grants to 169 communities and 16 new DFC Mentoring grants across the country.

3 Sep 2010

CaPre drug candidate shows promising result on CRP level reduction

Acasti Pharma Inc., a subsidiary of Neptune Technologies & Bioressources Inc. reports significant results on the effects of its anti-dyslipidemic investigational drug candidate CaPre on C-reactive protein (CRP) levels, a biomarker of CardioVascular Disease risk (CVD) and associated with diabetes and obesity.

3 Sep 2010

SXC Health Solutions declares nominal dividend on common shares

SXC Health Solutions Corp., a leading provider of pharmacy benefits management (PBM) services and Health Care Information Technology (HCIT) solutions to the healthcare benefits management industry, announced today that its board of directors has declared a nominal dividend on the issued and outstanding common shares of the Company to effect a two-for-one stock split.

2 Sep 2010

Orexigen and Takeda partner to develop, commercialize Contrave in US, Canada and Mexico

Orexigen® Therapeutics, Inc. and Takeda Pharmaceutical Company Limited, today announced that they have entered into an exclusive partnership to develop and commercialize Contrave® (naltrexone SR/bupropion SR), Orexigen's investigational drug for the treatment of obesity, in the United States, Canada and Mexico.

2 Sep 2010

Biodel replaces Linjeta with trade name VIAject

Biodel Inc. announced today that Linjeta™ (pronounced lin-JET-uh) will replace VIAject as the proposed trade name for Biodel's most advanced product candidate.

2 Sep 2010

Thomson Reuters announces acquisition of Healthcare Data Management

Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, today announced that it has acquired Healthcare Data Management, Inc. Effective immediately, the company will become part of the Healthcare & Science business of Thomson Reuters. Financial terms of the transaction were not disclosed.

2 Sep 2010

Indiana reports fewer preventable medical errors; Kansas struggles to meet oral health needs

The Indianapolis Star: "Indiana's hospitals and ambulatory surgery centers reported a decrease in preventable medical errors last year -- including a 33 percent drop in the number of bed sores. Overall, 306 facilities reported 94 preventable medical errors in 2009, according to a report released Monday by the Indiana State Department of Health. That's down from 105 errors reported each year in 2008 and 2007. The 22 pressure ulcers, also called bed sores, reported for 2009 were the fewest since the state's medical-error reporting system began four years ago" (Lee, 8/31).

2 Sep 2010

Support falls for health overhaul as Obama administration prepares for midterms

Kaiser Health News: Public support for the new health law slipped in August, "a development sure to stir concerns among the Obama administration and congressional Democrats seeking to shore up support for the law in the months leading up to the mid-term elections." The latest poll from the Kaiser Family Foundation found 43 percent of Americans viewed the law favorably, which is down from 50 percent in July.

2 Sep 2010

FDA extends Prescription Drug User Fee Act date for ezogabine

GlaxoSmithKline and Valeant Pharmaceuticals International announced today the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) goal date for ezogabine to 30 November 2010.

31 Aug 2010

Medicare beneficiaries receive prescription drug cost relief under Affordable Care Act

U.S. Department of Health and Human Services Secretary Kathleen Sebelius today announced that more than 1 million Medicare beneficiaries have received prescription drug cost relief through the Affordable Care Act.

31 Aug 2010

Emdeon Commercial MedRx solution launched to make commercial medical claims process efficient

Emdeon Inc., a leading provider of healthcare revenue and payment cycle management solutions, today announced the launch of Emdeon Commercial MedRx, a specialized processing solution that enables retail pharmacies to submit commercial medical claims electronically to medical payers and health plans across the U.S.

30 Aug 2010

Eisai receives new action date for FDA priority review of eribulin mesylate NDA for metastatic breast cancer

Eisai Inc. announced today that it has received notification from the U.S. Food and Drug Administration (FDA) that the agency expects to complete priority review of the eribulin mesylate New Drug Application (NDA) for locally advanced or metastatic breast cancer on or before December 30, 2010, which is a three month extension from the original Prescription Drug User Fee Act (PDUFA) action date of September 30, 2010.

30 Aug 2010

Protalix common stock receives approval for Tel Aviv Stock Exchange listing

Protalix BioTherapeutics, Inc.,a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins expressed through its proprietary plant cell based expression system, today announced that the Company's common stock has been approved for listing on the Tel Aviv Stock Exchange in addition to its current listing on the NYSE Amex.

30 Aug 2010

New research contradicts previous reports on blood-thinner clopidogrel

New findings by McMaster University researchers contradict earlier reports that people with a certain genetic make-up don't benefit from the blood-thinner clopidogrel, also known as Plavix.

30 Aug 2010

Montana Gov. seeks cheaper drugs for residents; Legal immigrants may lose health insurace in Mass.

The Associated Press: "Gov. Brian Schweitzer, cooking up a new plan to get cheaper prescription drugs for state residents, said he wants to let every Montanan get discounted medicine through Medicaid." It's his most recent idea about how "to either import cheaper name-brand prescriptions or to otherwise bypass what he sees as exorbitant prices charged by 'drug cartels.'"

27 Aug 2010

New alchemy module allows healthcare providers to verify, comply with state and federal prescription drug regulations

Gold Standard/Elsevier, developer of drug databases and medication management solutions, announced today the availability of its new Alchemy.

27 Aug 2010

HealthSpring announces acquisition of Bravo Health

HealthSpring, Inc. today announced that it has entered into a definitive agreement to acquire all of the outstanding capital stock of Bravo Health, Inc., an operator of Medicare Advantage coordinated care plans in Pennsylvania, the Mid-Atlantic region, and Texas, and Medicare Part D stand-alone prescription drug plans in 43 states.

27 Aug 2010

Today's Opinions: Sebelius on EMRs, primary care's role in reform and more

Health care providers may agree with the benefits of electronic health records. But they also believed that adopting them was too difficult and expensive. … [T]hat's changing - in large part due to an ambitious investment we made in the Recovery Act to reduce many of the obstacles that limited the spread of electronic health records in the past (HHS Secretary Kathleen Sebelius, 8/26).

27 Aug 2010

AARP Report finds increase in brand-name drug costs outstrips inflation

"Retail prices for some of the most widely used brand-name prescription drugs shot up more than 8 percent in 2009, even as inflation plummeted to a record low, according to a new AARP analysis of retail drug price trends released today.

26 Aug 2010

Prescription Drug News and Research

ASIPP announces educational campaign to improve chronic pain patients’ quality of life

National Drug Control Policy announces $22 million grant in DFC program

CaPre drug candidate shows promising result on CRP level reduction

SXC Health Solutions declares nominal dividend on common shares

Orexigen and Takeda partner to develop, commercialize Contrave in US, Canada and Mexico

Biodel replaces Linjeta with trade name VIAject

Thomson Reuters announces acquisition of Healthcare Data Management

Indiana reports fewer preventable medical errors; Kansas struggles to meet oral health needs

Support falls for health overhaul as Obama administration prepares for midterms

FDA extends Prescription Drug User Fee Act date for ezogabine

Medicare beneficiaries receive prescription drug cost relief under Affordable Care Act

Emdeon Commercial MedRx solution launched to make commercial medical claims process efficient

Eisai receives new action date for FDA priority review of eribulin mesylate NDA for metastatic breast cancer

Protalix common stock receives approval for Tel Aviv Stock Exchange listing

New research contradicts previous reports on blood-thinner clopidogrel

Montana Gov. seeks cheaper drugs for residents; Legal immigrants may lose health insurace in Mass.

New alchemy module allows healthcare providers to verify, comply with state and federal prescription drug regulations

HealthSpring announces acquisition of Bravo Health

Today's Opinions: Sebelius on EMRs, primary care's role in reform and more

AARP Report finds increase in brand-name drug costs outstrips inflation

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News